Establishing Brand Loyalty in Healthcare as a Futureproofing Strategy

The Future of Patient Experience Requires the Industry to Be Bold Creatively and Strategically

healthcare brand loyalty

The COVID-19 pandemic influenced consumers’ trust and engagement with healthcare, and challenged providers in innumerable, unforeseeable ways that today are helping establish digital platforms as the foundation for the industry’s customer service strategy.

NRC Health’s 2022 Healthcare Consumer Trends Report, which surveys more than 300,000 American households, provides insights into consumer sentiment that healthcare organizations can  use to find creative solutions that will help improve care delivery and enhance the patient experience (PX). And with nearly 35% consumers indicating no particular preference for a healthcare brand in 2021, hospitals and health systems have a sizeable opportunity to ensure that their brand is preferred.

The findings that providers can turn into opportunities for engaging with consumers and patients, as well as driving healthcare recall and brand awareness, include:

  • Delayed Care: Although care deferment decreased from 33% in the fourth quarter of 2020 to 27.1% during the fourth quarter of 2021, delays in care were greatest for preventative care. As a result, consumers seeking care today may be sicklier and costlier to treat. NRC recommends health systems and public health organizations begin to develop effective communications to assuage consumers’ concerns and encourage them to seek timely care, especially for preventative care needs. 
  • Mental Health: The mental health crisis that the pandemic has left in its tow has been equally as devastating. With nearly one-in-three consumers (30%) experiencing a worsening in their mental health during the pandemic, and related hospitalizations increasing nearly two-fold (190%) from 2020 to 2021,  the healthcare industry would be remiss if it does not take action now to mitigate and prevent the deleterious downstream effects that will continue to permeate long after the pandemic has passed.
  • Telehealth: Although levels of enthusiasm for and utilization of telehealth have waned from those experienced during the pandemic, consumer interest from the user perspectives of feasibility and usability, and across service lines, continues to be strong. However, NRC data indicates healthcare organizations need to be more strategic in determining which platform capabilities and for which consumers, services and staff, that telehealth offerings would be most effective operationally.

NRC data show that consumer healthcare recall is improving, with marketing recall having increased from 59.4% in 2020 to 64.5% in 2021. NRC also identifies encouraging signs for the industry’s digital healthcare efforts, which create opportunities to generate data and automate tasks to personalize communications and deliver to consumers the information they want, and where and when they want it. Mobile-responsive platforms offer significant opportunities for consumer access to that information (51.2%), with social media the third most recalled ad platform after television (38.7%) and billboards (11.8%). In particular, consumers report a 5.8% increase between 2020 and 2021 in helpful health information available from hospital websites. With visits to hospital websites reaching an all-time high of 31% as of November 2021, annual visitor traffic to hospital websites was up 4.6% between 2020 and 2021.

With healthcare organizations having opportunities to build their brands using personalization techniques and an omnichannel approach to target and engage active patients, NRC stresses that hospitals and health systems must meet consumers where they are. In particular, healthcare organizations need to develop a better understanding of patient preferences. Despite consumers’ likelihood of recommending hospitals and health systems increasing by about 3 percentage points to just over 23% in the year to November 2021, patient experience is not meeting expectations, with PX Net Promoter Scores declining from 56 in April 2020 to 44 in December 2021.

After decade-long investments of billions of dollars annually to boost patient recommendation scores, the return on investment has been negligible. And if providers are to make their brand  preferred among consumers, then organizations need to start recognizing that 99% of a patient’s life happens beyond the hospital care setting.

Author Information

Avatar photo

Andrew Broderick is a Senior Analyst contributing to Dash Research’s CX Advisory Service as well as Dash Network’s ongoing editorial coverage of Healthcare CX and Patient Experience. Based in San Francisco, Broderick has more than 20 years’ experience in technology research, analysis, and consulting, including an extensive background in digital health technologies and business practices.

Latest Insights:
Silicon Labs Q2 FY 2026 IoT Recovery Builds Momentum for Series 3 Platform
August 13, 2026
Article
Article

Silicon Labs Q2 FY 2026: IoT Recovery Builds Momentum for Series 3 Platform

Brendan Burke, Research Director at Futurum, analyzes Silicon Labs' Q2 FY 2026 earnings, focusing on sequential margin gains, the 22nm Series 3 up-market pivot, multi-protocol strategy, edge AI, and the pending Texas...
CoreWeave Q2 FY 2026 AI Demand Drives Pricing and Capacity Growth
August 13, 2026
Article
Article

CoreWeave Q2 FY 2026: AI Demand Drives Pricing and Capacity Growth

Futurum Research analyzes CoreWeave’s Q2 FY 2026 earnings, focusing on AI cloud demand, managed inference growth, power expansion, and raised FY 2026 guidance....
From Blaize to NVIDIA: Why Is AI Infrastructure Converging on Indonesia?
August 13, 2026
Article
Article

From Blaize to NVIDIA: Why Is AI Infrastructure Converging on Indonesia?

Brendan Burke, Research Director at Futurum, shares his insights on 100 days that put Blaize, CoreWeave, NVIDIA, Nokia, Firmus, and Indosat on Indonesia's sovereign AI map, and the generation-plus-distribution model that can...
Intuit's AI-Native Enterprise Suite Deepens Its Mid-Market Grip—Can SAP and Oracle Defend Downmarket?
August 13, 2026
Article
Article

Intuit’s AI-Native Enterprise Suite Deepens Its Mid-Market Grip—Can SAP and Oracle Defend Downmarket?

Intuit's Summer 2026 Enterprise Suite embeds generative AI and industry-specific workflows, positioning itself as the AI-native alternative to traditional ERP vendors for mid-market dominance....
Latest Research:
From Experimentation to Execution: Platform Engineering for Scalable Generative AI
August 10, 2026
Research
Research

From Experimentation to Execution: Platform Engineering for Scalable Generative AI

In our latest thought leadership report, From Experimentation to Execution: Platform Engineering for GenAI, completed in partnership with Red Hat, Futurum Research covers why enterprise GenAI initiatives stall before reaching...
August 5, 2026

Orchestrating IT at Global Scale How IBM Consulting Enabled Nestlé’s AI-Driven Delivery Model

In our latest case study, Orchestrating IT at global scale: How IBM Consulting enabled Nestlé's AI-driven delivery model, completed in partnership with IBM, Futurum Research examines how Nestlé consolidated a...
August 5, 2026

IBM as Client Zero: How IBM Built an Enterprise AI Orchestration Model at Global Scale

In our latest case study, IBM as Client Zero: How IBM built an enterprise AI orchestration model at global scale, completed in partnership with IBM, Futurum Research examines how IBM...

Book a Demo

Welcome

The vision behind everything in Futurum’s Custom Research practice is this: research should show you what is happening, what comes next, and what to do about it. It should be personal to each audience, easy for people to grasp, and structured so LLMs can reason over it accurately. And it should be fast and turnkey; you want answers now, not another project to carry for quarters.

Whether you are defining business, channel, or go-to-market strategy; evaluating vendors or justifying ROI; or commissioning research to fill an emerging market need, we have your back, with a program that answers your questions with the objectivity and credibility to drive real decisions.

To do it, we bring unmatched data to bear: Futurum research, surveys, and market projections; validated market feeds; ETR’s 15 years of insight from 10,000 technology decision-makers; G2’s buyer and user data; and what our analysts hear every day. Add leading primary collection, from AI-moderated voice interviews to surveys and analyst-led interviews, all turnkey, and every project comes out credible, nuanced, and actionable.

And we don’t just drop the results in your lap. For internal work, we provide analyst-led sessions, interactive dashboards, and a range of formats. For market-facing work, Futurum delivers turnkey activation and amplification that actually gets seen, by people and by LLMs, through our media and share of voice. This is research that moves decisions and markets.

We will meet you wherever you are, from a fast-turn brief to a multi-year program, and shape the work to your goals, timeline, and budget. The right program for your moment.

If any of this is useful, I would love to talk.

Benjamin Brown, VP Custom Research, Futurum Research

Benjamin Brown

VP, Custom Research · The Futurum Group

Newsletter Sign-up Form

Get important insights straight to your inbox, receive first looks at eBooks, exclusive event invitations, custom content, and more. We promise not to spam you or sell your name to anyone. You can always unsubscribe at any time.

All fields are required






Thank you, we received your request, a member of our team will be in contact with you.